Literature DB >> 2427266

Antigen specific immune response potential and HLA typing of Israeli patients with thyroid autoimmune diseases (TAD).

Y Shalev, Z Bentwich, D Katz, C Brautbar, E Mozes.   

Abstract

The immune response potential to the synthetic polypeptide antigen (T,G)-A--L was studied in 35 patients with thyroid autoimmune diseases (TAD). For this purpose the ability of their antigen activated peripheral blood lymphocytes (PBL) to generate a (T,G)-A--L specific helper factor was tested. In addition, the patients were typed for their HLA determinants. The results of the study have shown that 20/35 (57%) patients responded to (T,G)-A--L, a similar proportion to that found among healthy donors that were tested as control. No significant difference was found in the rate of responses between patients with Graves' disease and Hashimoto's thyroiditis. The responses in these groups of patients were shown to be 13/22 (59%) and 7/13 (54%) respectively. HLA typing of 26 patients with TAD did not demonstrate any association of the disease or the immune response potential with any specific HLA determinant. It is proposed that unlike the general lack of regulation that we have previously observed in patients with systemic lupus erythematosus, the abnormal autoimmune reaction in TAD and probably in other organ-specific autoimmune diseases, is towards a specific organ without affecting other arms and functions of the immune system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427266      PMCID: PMC1542342     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Suppressor cell function defect in idiopathic systemic lupus erythematosus.

Authors:  R S Krakauer; J D Clough; S Frank; J T Sundeen
Journal:  Clin Immunol Immunopathol       Date:  1979-11

2.  Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test.

Authors:  K K Mittal; M R Mickey; D P Singal; P I Terasaki
Journal:  Transplantation       Date:  1968-11       Impact factor: 4.939

3.  (T,G)-A-L specific immune response potential and HLA typing of Israeli patients with systemic lupus erythematosus.

Authors:  Y Shalev; Z Bentwich; D Katz; C Brautbar; E Mozes
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

Review 4.  HLA and disease 1982--a survey.

Authors:  A Svejgaard; P Platz; L P Ryder
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

5.  HLA-linked immune responsiveness to (T,G)-A-L: a family study.

Authors:  D Suez; D Katz; C Brautbar; T Cohen; Z Weisman; Z Bentwich; E Mozes
Journal:  Hum Immunol       Date:  1985-08       Impact factor: 2.850

Review 6.  Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture.

Authors:  P I Terasaki; D Bernoco; M S Park; G Ozturk; Y Iwaki
Journal:  Am J Clin Pathol       Date:  1978-02       Impact factor: 2.493

7.  Influenza immunization in systemic lupus eruthematosus. A double-blind trial.

Authors:  G W Williams; A D Steinberg; J L Reinertsen; L W Klassen; J L Decker; R Dolin
Journal:  Ann Intern Med       Date:  1978-06       Impact factor: 25.391

8.  Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus.

Authors:  W W Ginsburg; F D Finkelman; P E Lipsky
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

9.  Immune response potential to poly(Tyr,Glu)-poly(DLAla)--poly(Lys) of human T cells of different donors.

Authors:  D Katz; Z Bentwich; N Eshhar; I Löwy; E Mozes
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

10.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.